Back to rankings

AXA SA (AXAHF)

NEUTRAL
Financial ServicesInsurance - DiversifiedFrance

Fundamental

63

Price

$43.68

Market Cap

$91.71B

Part 1 · What the company is worth

Overview

AXA insures homes, cars, businesses and people against loss, illness and death, and sells life-savings and health policies alongside its property and casualty business. It collects premiums from millions of policyholders across Europe, Asia and elsewhere, and its AXA XL unit specializes in large commercial and specialty risks. A much smaller asset management arm invests money for clients for a fee.

How it makes money

Premiums are collected upfront and claims are paid later, sometimes decades later for life and health policies, so profit comes from underwriting discipline — pricing risk correctly — plus the investment income earned on the funds held in between. Asset management adds a smaller, fee-based income stream that depends on the value of assets managed rather than on claims experience.

Revenue by segment

Property & Casualty50.3%

Insurance for cars, homes, businesses and large commercial and specialty risks, including through the AXA XL unit.

Life & Health49%

Savings, protection and health policies, with health premiums growing faster than the rest of the group in the latest year.

Asset Management0.8%

Fee-based investment management, now much smaller after the 2025 sale of AXA Investment Managers to BNP Paribas.

Competitive moat

Scale · Narrow

A global brand, broad distribution and a large capital base give AXA underwriting and pricing advantages over smaller insurers. The advantage is not exclusive, however: several other large composite insurers operate at similar scale in AXA's core European and Asian markets, and policyholders can and do switch insurers at renewal.

What drives demand

Defensive

Car, home and liability insurance are largely mandatory or near-mandatory, so premium volumes hold up through economic downturns better than most consumer businesses. Growth still responds to the economy at the margin, through new business formation, asset values for savings products, and how much coverage households choose to buy.

Key risks

  • Frequency and severity of insured losses — The company lists the frequency and severity of insured loss events, including weather-related catastrophes, as a main risk factor; it targets a normalized natural-catastrophe load of about 4.5 points of the combined ratio, and a worse year than that assumption directly hits underwriting profit.
  • Interest rate and market conditions — The company identifies market performance and exchange- and interest-rate fluctuations as a key risk, since they affect both the value of the investment portfolio backing its policies and the cost of long-term savings guarantees.
  • Mortality and morbidity assumptions — Life and health results depend on how actual mortality and morbidity compare with the assumptions used to price policies decades in advance; the company lists these levels among its principal risk factors.

The case for

Buyers argue that growth across both Property & Casualty and Life & Health in 2025, together with a still-comfortable Solvency II capital ratio, shows a diversified and well-capitalized insurer, and that the sale of the asset management arm sharpens the focus on the core, better-margin insurance business.

The case against

Sellers fear that a normalized natural-catastrophe assumption of 4.5 points can be exceeded in a genuinely bad year for weather losses, that a large long-duration life book stays exposed to interest-rate swings for decades, and that the Solvency II capital ratio has already declined from year-end 2025 levels, leaving less buffer than before.

Written by the editors, published on August 18, 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on August 23, 2026 with claude-opus-5 — shared with all users

P/E: 10.6Score: 68Market cap: $195.01B

Europe's other large multiline insurer, competing with AXA for the same retail, health and corporate property-and-casualty customers in Germany, France, Italy and Asia.

Assicurazioni Generali S.p.A.G

Sells life, health and property-and-casualty policies through agent networks in the same Continental European markets where AXA earns most of its premiums, Italy and France above all.

Zurich Insurance Group AGZURN

Goes head-to-head with AXA XL for the global commercial property-and-casualty programmes of large corporations, and with AXA's retail arms in Switzerland, Germany and Italy.

Chubb LimitedCB

Writes the same large-corporate and specialty property-and-casualty risks that AXA XL underwrites, competing broker by broker for the same commercial accounts.

Covéa (MAAF, MMA, GMF)Not tracked

France's leading motor and home insurer, disputing with AXA France the same domestic retail policyholders that make France AXA's largest single market.

Aviva plcAV.

Competes with AXA's UK and Irish operations for the same general insurance, group health and commercial customers.

Balance Sheet & Liquidity

Revenue

$96.20B

Trailing 12 months to the last reported quarter — estimated from per-share metrics

Net Income

$10.17B

Trailing 12 months to the last reported quarter — estimated from per-share metrics

Free Cash Flow

$-26.39B

Total Equity

$46.19B

Total Liabilities

$61.11B

Current Ratio

11.53

Interest Coverage

-

Debt/EBITDA

-

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

Undervalued

Fair Value

$82.95

Current Price

$43.68

Margin of Safety

+47.3%

Fair Value Range

$53.92 - $111.98

Estimation Methods

Analyst Target:$50.51
DCF:$132.71
PE-based:$37.13
Graham Growth:$190.99
EPV:$42.55
Analyst Consensus:Strong Buy (25B / 3H / 0S)
Last Earnings Surprise:-2.91%

Valuation Metrics

P/E Ratio

9.07

ROE

14.9%

P/B Ratio

2.00

P/FCF

-

Gross Margin

14.9%

ROIC

8.5%

Profitability Radar

Value Creation (Economic Moat)

ROIC

8.5%

WACC

5.9%

ROIC − WACC

+2.6 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Fundamental Analysis Criteria

Passed (12)

  • Price CAGR 6.77%
  • ROIC 8.5%
  • P/B Ratio 2.00
  • Debt/Equity ratio
  • Operating Margin 11.6%
  • Current Ratio
  • Price below Graham Number
  • ROE 21.9%
  • Analyst Consensus 89% Buy
  • PEG Ratio 0.32
  • Earnings Quality (OCF/NI) 1.52
  • Net Margin Trend 10.7% vs 9.0%

Failed (6)

  • Gross Margin 14.9%
  • Positive Free Cash Flow
  • DCF valuation (Unknown)
  • Revenue Growth 5Y -4.2%
  • Earnings Surprise avg -2.0%
  • Piotroski F-Score 2/9

Unavailable (9)

  • EPS data insufficient
  • P/FCF NaN
  • Dividend Payout NaN%
  • CapEx intensity
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Share Dilution (missing shares data)

Piotroski F-Score

2/9

Serious financial concerns

score
criteria

Earnings Quality

1.52

High quality: earnings backed by cash

Share Dilution

-

Buying back shares. Shareholder friendly

Governance

Executive Team

NameTitleAge
Dr. Thomas Buberl Ph.D.CEO & Director52
Ms. Helen BrowneGroup General Counsel & Employee Shareholders Representative Director63
Mr. Alban de Mailly NesleGroup Chief Financial Officer55
Gregoire de MontchalinChief Accounting & Reporting Officer-
Mr. Matthieu CaillatGroup Chief Technology & AI Officer, Chief Executive Officer of AXA Group Operations-
Ms. Anu VenkataramanGroup Chief Strategy Officer & Head of Investor Relations-
Ms. Ulrike DecoeneGroup Chief Communication, Brand & Sustainability Officer-
Ms. Karima SilventDeputy General Secretary, in charge of HR, Compliance, Audit, AXA EssentiALL & GIE AXA51
Mr. Hassan El-ShabrawishiChief Executive Officer of International Markets-
Mr. Guillaume BorieGlobal Head of Finance, Strategy, Underwriting, Risk & Technology39

Audit Risk

3

Board Risk

2

Compensation Risk

6

Shareholder Rights Risk

6

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Latest News

Recent headlines for AXAHF, sourced from Markets Gazette.

No recent news for AXAHF.